LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.62 | 84.90 | 582 | 2449 | 0.2376 | 0.4871 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.62 | 84.90 | 1492 | 2449 | 0.6091 | 0.8057 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.32 | 84.90 | 74 | 2722 | 0.0272 | -0.0271 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.32 | 84.90 | 1342 | 2722 | 0.4930 | 0.7363 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.32 | 84.90 | 725 | 2722 | 0.2663 | 0.5352 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 33.32 | 84.90 | 1569 | 2722 | 0.5763 | 0.7914 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 35.03 | 84.90 | 87 | 2991 | 0.0291 | 0.0048 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 35.03 | 84.90 | 1408 | 2991 | 0.4707 | 0.7272 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 35.03 | 84.90 | 857 | 2991 | 0.2865 | 0.5682 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 35.03 | 84.90 | 1646 | 2991 | 0.5503 | 0.7805 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.73 | 84.90 | 105 | 3254 | 0.0323 | 0.0412 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.73 | 84.90 | 1467 | 3254 | 0.4508 | 0.7189 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.73 | 84.90 | 1290 | 3254 | 0.3964 | 0.6774 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.73 | 84.90 | 1728 | 3254 | 0.5310 | 0.7733 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.43 | 84.90 | 128 | 3459 | 0.0370 | 0.0798 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.43 | 84.90 | 1543 | 3459 | 0.4460 | 0.7198 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.43 | 84.90 | 1480 | 3459 | 0.4278 | 0.7064 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.43 | 84.90 | 1775 | 3459 | 0.5131 | 0.7654 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.14 | 84.90 | 126 | 3682 | 0.0342 | 0.0753 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.14 | 84.90 | 1594 | 3682 | 0.4329 | 0.7147 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.14 | 84.90 | 1550 | 3682 | 0.4210 | 0.7058 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 40.14 | 84.90 | 1812 | 3682 | 0.4921 | 0.7555 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.84 | 84.90 | 127 | 4003 | 0.0317 | 0.0751 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.84 | 84.90 | 1649 | 4003 | 0.4119 | 0.7051 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.84 | 84.90 | 1562 | 4003 | 0.3902 | 0.6885 | MN20160318_Q02 | K11 |